Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Decoy peptide targeted to Toll-IL-1R domain inhibits LPS and TLR4-active metabolite morphine-3 glucuronide sensitization of sensory neurons.

Allette YM, Kim Y, Randolph AL, Smith JA, Ripsch MS, White FA.

Sci Rep. 2017 Jun 16;7(1):3741. doi: 10.1038/s41598-017-03447-9.

2.

A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors.

Imbert PR, Louche A, Luizet JB, Grandjean T, Bigot S, Wood TE, Gagné S, Blanco A, Wunderley L, Terradot L, Woodman P, Garvis S, Filloux A, Guery B, Salcedo SP.

EMBO J. 2017 Jul 3;36(13):1869-1887. doi: 10.15252/embj.201695343. Epub 2017 May 8.

3.

Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.

Jezierska A, Kolosova IA, Verin AD.

Curr Signal Transduct Ther. 2011;6(3):428-440. doi: 10.2174/157436211797483930.

4.

Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity.

Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, Chrabieh M, Lemmens NA, Sancho-Shimizu V, Descatoire M, Lasseau T, Israelsson E, Lorenzo L, Yun L, Belkadi A, Moran A, Weisman LE, Vandenesch F, Batteux F, Weller S, Levin M, Herberg J, Abhyankar A, Prando C, Itan Y, van Wamel WJ, Picard C, Abel L, Chaussabel D, Li X, Beutler B, Arkwright PD, Casanova JL, Puel A.

Cell. 2017 Feb 23;168(5):789-800.e10. doi: 10.1016/j.cell.2017.01.039.

PMID:
28235196
5.

MyD88 Adapter-like (Mal)/TIRAP Is Required for Cytokine Production by Splenic Ly6CloTLR2hi but Not by Ly6ChiTLR2hi Monocytes during Trypanosoma cruzi Infection.

Gravina HD, Goes AM, Murta SM, Ropert C.

J Biol Chem. 2016 Nov 4;291(45):23832-23841. Epub 2016 Sep 19.

PMID:
27646001
6.

A Common Variant in the Adaptor Mal Regulates Interferon Gamma Signaling.

Ní Cheallaigh C, Sheedy FJ, Harris J, Muñoz-Wolf N, Lee J, West K, McDermott EP, Smyth A, Gleeson LE, Coleman M, Martinez N, Hearnden CH, Tynan GA, Carroll EC, Jones SA, Corr SC, Bernard NJ, Hughes MM, Corcoran SE, O'Sullivan M, Fallon CM, Kornfeld H, Golenbock D, Gordon SV, O'Neill LA, Lavelle EC, Keane J.

Immunity. 2016 Feb 16;44(2):368-79. doi: 10.1016/j.immuni.2016.01.019.

7.

The kinase activity of PKR represses inflammasome activity.

Yim HC, Wang D, Yu L, White CL, Faber PW, Williams BR, Sadler AJ.

Cell Res. 2016 Mar;26(3):367-79. doi: 10.1038/cr.2016.11. Epub 2016 Jan 22.

8.

EGFR kinase activity is required for TLR4 signaling and the septic shock response.

Chattopadhyay S, Veleeparambil M, Poddar D, Abdulkhalek S, Bandyopadhyay SK, Fensterl V, Sen GC.

EMBO Rep. 2015 Nov;16(11):1535-47. doi: 10.15252/embr.201540337. Epub 2015 Sep 4.

9.

Deconstructing innate immune signaling in myelodysplastic syndromes.

Varney ME, Melgar K, Niederkorn M, Smith M, Barreyro L, Starczynowski DT.

Exp Hematol. 2015 Aug;43(8):587-598. doi: 10.1016/j.exphem.2015.05.016. Epub 2015 Jul 2. Review.

10.

Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.

Huang HF, Zeng Z, Wang KH, Zhang HY, Wang S, Zhou WX, Wang ZB, Xu WG, Duan J.

World J Gastroenterol. 2015 Mar 14;21(10):2937-48. doi: 10.3748/wjg.v21.i10.2937.

11.

Catching the adaptor-WDFY1, a new player in the TLR-TRIF pathway.

Nandakumar R, Paludan SR.

EMBO Rep. 2015 Apr;16(4):397-8. doi: 10.15252/embr.201540145. Epub 2015 Mar 3.

12.

AIP1-mediated stress signaling in atherosclerosis and arteriosclerosis.

Zhang J, Zhou HJ, Ji W, Min W.

Curr Atheroscler Rep. 2015 May;17(5):503. doi: 10.1007/s11883-015-0503-z. Review.

13.

Innate immune pattern recognition: a cell biological perspective.

Brubaker SW, Bonham KS, Zanoni I, Kagan JC.

Annu Rev Immunol. 2015;33:257-90. doi: 10.1146/annurev-immunol-032414-112240. Epub 2015 Jan 2. Review.

14.

MyD88: a central player in innate immune signaling.

Deguine J, Barton GM.

F1000Prime Rep. 2014 Nov 4;6:97. doi: 10.12703/P6-97. eCollection 2014. Review.

15.

Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Chintala SK, Putris N, Geno M.

Invest Ophthalmol Vis Sci. 2015 Jan 6;56(1):505-14. doi: 10.1167/iovs.14-15539.

16.

SMOCs: supramolecular organizing centres that control innate immunity.

Kagan JC, Magupalli VG, Wu H.

Nat Rev Immunol. 2014 Dec;14(12):821-6. doi: 10.1038/nri3757. Epub 2014 Oct 31. Review.

17.

Molecular and cellular regulation of toll-like receptor-4 activity induced by lipopolysaccharide ligands.

Liaunardy-Jopeace A, Gay NJ.

Front Immunol. 2014 Oct 6;5:473. doi: 10.3389/fimmu.2014.00473. eCollection 2014. Review.

18.

Responses of innate immune cells to group A Streptococcus.

Fieber C, Kovarik P.

Front Cell Infect Microbiol. 2014 Oct 2;4:140. doi: 10.3389/fcimb.2014.00140. eCollection 2014. Review.

19.

TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens.

McClure R, Massari P.

Front Immunol. 2014 Aug 12;5:386. doi: 10.3389/fimmu.2014.00386. eCollection 2014. Review.

20.

Role of Toll-like receptors in Helicobacter pylori infection and immunity.

Smith SM.

World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):133-46. doi: 10.4291/wjgp.v5.i3.133. Review.

Supplemental Content

Support Center